This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Medical Practice  • Health Policy  • Neurology  • Neurocutaneous Diseases  • Dermatologic Disorders  • Screening  • Dermatologic Disorders, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Dermatology or Economics and Public Policy?

Arch Dermatol. 2005;141:78-79.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In this issue of the ARCHIVES, Lammert et al¹ document that screening for neurofibromatosis 1 (NF1) among children entering school can be accomplished efficiently and inexpensively in Germany. Can we conclude from this article that an NF1 screening program should be established in the United States? I believe the answer to this question is yes. However, there are at least 2 additional considerations. The first has to do with potential resistance by persons with NF1, particularly those who are active in various NF1 support groups. The second concern has to do with how readily the German model can be translated to the United States. In Germany, the marginal cost of adding NF1 to the screening system was minimal: simply sensitize a relatively small number of physicians to the presence of several readily detectable features of NF1. In the United States, a huge number of clinicians, only some of . . . [Full Text of this Article]

AUTHOR INFORMATION
Vincent M. Riccardi, MD

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Prevalence of Neurofibromatosis 1 in German Children at Elementary School Enrollment
Marga Lammert, Jan M. Friedman, Lan Kluwe, and Victor F. Mautner
Arch Dermatol. 2005;141(1):71-74.
ABSTRACT | FULL TEXT